TRVN (Trevena Inc) Yalpi foyda bo'yicha rentabellik

TRVN (Trevena Inc) - kompaniyaning tovar belgisi

Trevena, Inc. xavfsiz og'riq qoldiruvchi vositalarni, jumladan Olinvyk dori vositasini ishlab chiqadi va GURU.Markets grafigidagi joriy yalpi foyda marjasi ishlab chiqarish samaradorligini namoyish etadi; 0.00 qiymati ushbu metrikaning muvozanatini aks ettiradi. Klinik sinovlarning aniqligi bu yerda ma'lumotlar tahlilini avtomatlashtirish orqali ta'minlanadi. Avtonom mahsulot sikli tufayli kompaniya global makroiqtisodiy tebranishlardan mustaqil bo'lgan defensiv aktiv bo'lib qolmoqda.

TRVN Trevena Inc Yalpi foyda bo'yicha rentabellik (04.07.2022 - 19.10.2024)

Trevena, Inc. (TRVN) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- kotirovkalar va tahlilchilar prognozi:
Kompaniyaning asosiy tahlili:Trevena Inc.
Trevena Inc tomonidan chiqariladigan mahsulotlar

Trevena, Inc. markaziy nerv tizimi terapiyasi va og'riqlarni boshqarish uchun innovatsion dori vositalarini ishlab chiqishga ixtisoslashgan. Ushbu ko'rsatkich sotilgan tovarlarning bevosita xarajatlarini chegirib tashlagandan keyin qolgan daromad ulushini aniqlash orqali ishlab chiqarish samaradorligini o'lchaydi. Valo daromad marjasini tahlil qilish patent himoyasi kompaniyaning narx belgilash imkoniyatlariga qanday ta'sir qilishini baholash imkonini beradi, bu esa uning fundamental barqarorligini va yuqori operatsion marjalarni yaratish qobiliyatini tasdiqlaydi.

Asosiy raqobatchilar

Yalpi foyda bo'yicha rentabellik Biogen Corp|Yalpi foyda bo'yicha rentabellik NBIX|Regencell Corp (RGC) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja AXSM|Yalpi foyda bo'yicha rentabellik ACADIA Pharmaceuticals ACAD|Yalpi marja XENE (Xenon Pharmaceuticals Inc.)|VKTX (Viking Therapeutics, Inc.) - Yalpi foyda bo'yicha marjinallik|SUPN - Yalpi rentabellik|Catalyst Pharmaceuticals Inc (CPRX) - Yalpi foyda bo'yicha rentabellik|DNLI (Denali Corp) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi harmonybiosciences.com (HRMY)|Yalpi foyda bo'yicha rentabellik BHVN|Yalpi marja Amylyx|Yalpi marja TRVI|PRAX (Praxis Corp) - Yalpi foyda normasi|Yalpi marja AVXL (anavex.com)|CBLL: Sotuvning yalpi rentabelligi|PRTA - Yalpi rentabellik|ALEC - Yalpi marja|Annexon Inc. (ANNX) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Omeros Corp|Yalpi foyda bo'yicha rentabellik NGNE|ACIU: Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik VYGR (Voyager Corp)|Yalpi foyda bo'yicha rentabellik Neumora NMRA|Yalpi rentabellik Scilex Holding Company, Inc. SCLX|Sotuvning yalpi marjinal rentabelligi Tevogen Bio Inc.|ACOG - Yalpi rentabellik|Sotuvning yalpi marjinal rentabelligi Cognition Therapeutics (CGTX)|IKT (Inhibikase Therapeutics) - Yalpi foyda bo'yicha rentabellik|Cassava Sciences Inc (SAVA) - Yalpi marja|Yalpi foyda bo'yicha rentabellik ASRT|Yalpi marja coyatherapeutics.com|Yalpi marja VTGN|Ovid Therapeutics - Sotuvning yalpi rentabelligi|Yalpi marja ABOS (Acumen Pharmaceuticals, Inc)|CRVO - Yalpi foyda bo'yicha rentabellik|ATHE - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi clene.com CLNN|PEPG: Yalpi marja|Sotuvning yalpi rentabelligi JUNS|RLMD (Relmada Corp) - Yalpi marja|Annovis Bio Inc (ANVS) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Grace Therapeutics, Inc. (GRCE)|AIFF (Firefly Neuro) - Yalpi foyda normasi|Yalpi rentabellik Klotho Neurosciences KLTO|NRSN: Sotuvning yalpi rentabelligi|RVPH: Yalpi foyda bo'yicha rentabellik|MTVA: Yalpi rentabellik|NRXS (NeurAxis Inc) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik Helius Medical Technologies, Inc.|Yalpi rentabellik Passage Bio Inc.|Yalpi foyda marjasi bionomics.com.au NEUP|Yalpi marja NERV|Yalpi marja Athira Pharma Inc (ATHA)|Yalpi marja ADXN (Addex Therapeutics Ltd.)|ALZN: Sotuvning yalpi rentabelligi|CYCN - Yalpi rentabellik|Yalpi foyda marjasi Protagenic Therapeutics, Inc.|KTTA (pasitheaclinics.com) - Yalpi foyda bo'yicha rentabellik|Sotuvning yalpi marjinal rentabelligi Cortigent, Inc. CRGT|Yalpi rentabellik Avenue Therapeutics, Inc.|Yalpi foyda bo'yicha rentabellik BrainStorm Cell Therapeutics Inc. (BCLI)|Yalpi rentabellik Cara Therapeutics, Inc (CARA)|Yalpi rentabellik CHRO (Chromocell Therapeutics Corp.)|Yalpi marja ELYM (eliemtx.com)|intracellulartherapies.com - Yalpi rentabellik|LBPH: Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi MRNS (Marinus Pharma)|NKGN (nkgenbiotech.com) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik NeuroBo Pharmaceuticals|SAGE (Sage Therapeutics Inc.) - Yalpi marja|Neurotrope - Yalpi foyda bo'yicha marjinallik|Yalpi marja VIGL|Yalpi marja anewmeds.com (WENA)|Yalpi marja CERE (cerevel.com)